CELH
Celsius Holdings, Inc.
CELH has the edge over MH overall, supported by stronger fundamentals and stronger valuation.
MH
McGraw Hill, Inc.
MH's outlook is improving, though it still trails on the overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
MH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Under pressure |
MH's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is under pressure.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
MH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 5.7x | $11.04 | — |
| Cheap | 27x | $9.82 | -11% |
| Fair | 29x | $10.83 | -1.9% |
| Current | 30x | $11.04 | — |
| Expensive | 53x | $19.61 | +78% |
Historical ranges are pointers, not guarantees.
MH has the edge over CELH in the historical PE scenario, which offers more potential upside but is not a forecast.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
MH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for MH, with profitability improving. However, they disagree widely on these estimates.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
MH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.93 | +421% |
| Q3 2026 | $0.37 | +$0.90 |
| Q2 2026 | $0.49 | +$0.89 |
| Q1 2026 | $0.19 | +$0.64 |
| Q4 2025 | -$0.36 | +$0.03 |
| Q3 2025 | -$0.53 | -$0.02 |
| Q2 2025 | -$0.40 | +$0.49 |
| Q1 2025 | -$0.45 | +$0.56 |
| Q4 2024 | -$0.39 | +$0.50 |
MH has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over MH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH's operating margin was 20% last quarter, up 31 points from the same quarter a year ago.
MH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $632.2M | -5.5% |
| Q2 2026 | $549.9M | +2.6% |
| Q1 2026 | $463.7M | -2% |
| Q4 2025 | $434.2M | +4.2% |
| Q3 2025 | $669.2M | -2.8% |
| Q2 2025 | $535.7M | +2.4% |
| Q1 2025 | $473.3M | +13% |
| Q4 2024 | $416.5M | +4.4% |
MH's revenue grew through 2023 and has held roughly level since: $632M last quarter, down 5.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 22% | -1.1 points |
| Q2 2026 | 21% | +2.8 points |
| Q1 2026 | -1.4% | -7.2 points |
| Q4 2025 | 7% | +1.2 points |
| Q3 2025 | 23% | -2.6 points |
| Q2 2025 | 18% | +3.5 points |
| Q1 2025 | 5.9% | +16 points |
| Q4 2024 | 5.8% | +2.4 points |
MH has the edge over CELH on profitability, with a higher operating margin.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
MH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $164.1M | -33% |
| Q2 2026 | -$23.3M | +$89.6M |
| Q1 2026 | -$169.9M | -$70.8M |
| Q4 2025 | $285.4M | +19% |
| Q3 2025 | $243.8M | -39% |
| Q2 2025 | -$112.9M | -$94.1M |
| Q1 2025 | -$99.2M | +$42.7M |
| Q2 2024 | -$18.8M | +$84.5M |
MH still generates free cash flow, though less than at its 2024 peak: $256M over the past year.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over MH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
MH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +189K shares |
| 1 year | +3% | +5.7M shares |
| 3 years | +0.3% | +496K shares |
MH has 191M diluted shares, up 3% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over MH on leverage, with a lower net debt burden relative to earnings.
MH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.6x | Elevated |
| Q2 2026 | 3.7x | Elevated |
| Q1 2026 | 3.6x | Elevated |
| Q4 2025 | 3.2x | Elevated |
| Q3 2025 | 3.6x | Elevated |
| Q2 2025 | 4.3x | High |
| Q1 2025 | 4.3x | High |
| Q4 2024 | 4.2x | High |
MH's net debt is about 3.6 years of its operating earnings (EBITDA), about the same as a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
MH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.3 | Neutral |
| Stochastic | 32.7 | Neutral |
MH's weekly RSI is 41 (neutral) and its Stochastic is 33 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
MH PE vs Consumer Defensive Sector
| Metric | MH | Sector median | Relative |
|---|---|---|---|
| PE | 30x | 19x | 53% above |
| PE % | 55 | 37 | 18 pts above |
MH has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has stronger trend alignment. CELH is above 2 of 5 weekly averages versus MH above 0 of 3.
MH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.9 | 14% below |
| 20 week MA | $12.2 | 9.3% below |
| 50 week MA | $13.1 | 15% below |
MH is in a downtrend: it's below all three of its weekly moving averages, and 15% below its 50-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over MH on returns for 2026, with the stronger performance.
MH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $16.8 | $17.0 | +1.1% |
| 2026 YTD | $17.0 | $11.0 | -35% |
MH has finished every year since 2025 higher, and it's down 35% so far in 2026.